Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hitoshi Hanamoto
A 5-Day Regimen of Azacitidine for Lower-Risk Myelodysplastic Syndromes (RA or RARS): A Prospective Single-Arm Phase 2 Trial
Cancer Science
Cancer Research
Medicine
Oncology
Related publications
Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prospective Trial of Pre-Transplant 5-Azacitidine on Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndrome and CMML
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Combination of Chidamide With Choep Regimen in Previously Untreated Patients With Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cost-Effectiveness in Canada of Azacitidine for the Treatment of Higher-Risk Myelodysplastic Syndromes
Current Oncology
Oncology
Epigenetic Approaches in the Treatment of Myelodysplastic Syndromes: Clinical Utility of Azacitidine
OncoTargets and Therapy
Oncology
Pharmacology
Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes
International Journal of Hematology
Hematology
Colorectal Liver Metastatic Disease: Efficacy of Irreversible Electroporation—a Single-Arm Phase II Clinical Trial (COLDFIRE-2 Trial)
BMC Cancer
Cancer Research
Oncology
Genetics
BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Frontiers in Oncology
Cancer Research
Oncology
